magnify 发表于 2025-3-21 16:22:29
书目名称Improvement of Myocardial Perfusion影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0462754<br><br> <br><br>书目名称Improvement of Myocardial Perfusion读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0462754<br><br> <br><br>AVOID 发表于 2025-3-21 21:20:53
http://reply.papertrans.cn/47/4628/462754/462754_2.png澄清 发表于 2025-3-22 00:42:08
http://reply.papertrans.cn/47/4628/462754/462754_3.png证明无罪 发表于 2025-3-22 06:14:44
http://reply.papertrans.cn/47/4628/462754/462754_4.png同来核对 发表于 2025-3-22 11:25:17
Thrombolytic therapy in myocardial infarction: Are fibrinolytic drugs comparable, and similarly effeMany authors consider that SK and UK are both useful thrombolytic agents . They also consider that the choice between SK and UK is influenced by economic considerations .认识 发表于 2025-3-22 14:48:34
ECG and reperfusionThe most important tool for the diagnosis of an acute myocardial infarction (a MI) is the ECG. ST segment elevation can be seen within a few seconds after complete occlusion of a coronary artery. During the next 6 to 8 hours there is a loss or reduction of R-waves and a development of pathological Q-waves .富足女人 发表于 2025-3-22 20:00:29
http://reply.papertrans.cn/47/4628/462754/462754_7.pngNOMAD 发表于 2025-3-22 22:14:18
http://reply.papertrans.cn/47/4628/462754/462754_8.pngoutrage 发表于 2025-3-23 02:13:22
http://reply.papertrans.cn/47/4628/462754/462754_9.png结束 发表于 2025-3-23 08:28:52
Efficacy of BRL 26921, a new fibrinolytic agent for intravenous infusion, in acute myocardial infarche size of myocardial infarction. Intracoronary thrombolysis has shown to be more successful than intravenous fibrinolysis . The major disadvantage of the technique is the delay in starting the treatment, caused by the need for selective coronary angiography.